Cargando…

Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function

Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after suppl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Dawei, Alamri, Yassar, Liu, Karen, MacAskill, Michael, Harris, Paul, Brimble, Margaret, Dalrymple-Alford, John, Prickett, Tim, Menzies, Oliver, Laurenson, Andrew, Anderson, Tim, Guan, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024688/
https://www.ncbi.nlm.nih.gov/pubmed/29865234
http://dx.doi.org/10.3390/nu10060714
_version_ 1783336109963476992
author Fan, Dawei
Alamri, Yassar
Liu, Karen
MacAskill, Michael
Harris, Paul
Brimble, Margaret
Dalrymple-Alford, John
Prickett, Tim
Menzies, Oliver
Laurenson, Andrew
Anderson, Tim
Guan, Jian
author_facet Fan, Dawei
Alamri, Yassar
Liu, Karen
MacAskill, Michael
Harris, Paul
Brimble, Margaret
Dalrymple-Alford, John
Prickett, Tim
Menzies, Oliver
Laurenson, Andrew
Anderson, Tim
Guan, Jian
author_sort Fan, Dawei
collection PubMed
description Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency.
format Online
Article
Text
id pubmed-6024688
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60246882018-07-08 Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function Fan, Dawei Alamri, Yassar Liu, Karen MacAskill, Michael Harris, Paul Brimble, Margaret Dalrymple-Alford, John Prickett, Tim Menzies, Oliver Laurenson, Andrew Anderson, Tim Guan, Jian Nutrients Article Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency. MDPI 2018-06-02 /pmc/articles/PMC6024688/ /pubmed/29865234 http://dx.doi.org/10.3390/nu10060714 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fan, Dawei
Alamri, Yassar
Liu, Karen
MacAskill, Michael
Harris, Paul
Brimble, Margaret
Dalrymple-Alford, John
Prickett, Tim
Menzies, Oliver
Laurenson, Andrew
Anderson, Tim
Guan, Jian
Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title_full Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title_fullStr Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title_full_unstemmed Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title_short Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
title_sort supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of parkinson patients: potential treatment to improve insulin-like growth factor-1 function
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024688/
https://www.ncbi.nlm.nih.gov/pubmed/29865234
http://dx.doi.org/10.3390/nu10060714
work_keys_str_mv AT fandawei supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT alamriyassar supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT liukaren supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT macaskillmichael supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT harrispaul supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT brimblemargaret supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT dalrymplealfordjohn supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT pricketttim supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT menziesoliver supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT laurensonandrew supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT andersontim supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function
AT guanjian supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function